CA1197191A - Composition pharmaceutique antihypertensive synergetique - Google Patents

Composition pharmaceutique antihypertensive synergetique

Info

Publication number
CA1197191A
CA1197191A CA000432068A CA432068A CA1197191A CA 1197191 A CA1197191 A CA 1197191A CA 000432068 A CA000432068 A CA 000432068A CA 432068 A CA432068 A CA 432068A CA 1197191 A CA1197191 A CA 1197191A
Authority
CA
Canada
Prior art keywords
indapamide
pharmaceutical composition
tert
compounds
antihypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000432068A
Other languages
English (en)
French (fr)
Inventor
Daniel Molle
Etienne Labeyrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of CA1197191A publication Critical patent/CA1197191A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000432068A 1982-07-09 1983-07-08 Composition pharmaceutique antihypertensive synergetique Expired CA1197191A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR82.12058 1982-07-09
FR8212058A FR2529785A1 (fr) 1982-07-09 1982-07-09 Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne

Publications (1)

Publication Number Publication Date
CA1197191A true CA1197191A (fr) 1985-11-26

Family

ID=9275835

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000432068A Expired CA1197191A (fr) 1982-07-09 1983-07-08 Composition pharmaceutique antihypertensive synergetique

Country Status (16)

Country Link
JP (1) JPS5927813A (xx)
AU (1) AU557601B2 (xx)
BE (1) BE897251A (xx)
CA (1) CA1197191A (xx)
CH (1) CH655007A5 (xx)
DE (1) DE3324785C2 (xx)
FR (1) FR2529785A1 (xx)
GB (1) GB2123293B (xx)
IE (1) IE55364B1 (xx)
IT (1) IT1173729B (xx)
LU (1) LU84902A1 (xx)
NL (1) NL8302435A (xx)
NZ (1) NZ204849A (xx)
OA (1) OA07489A (xx)
SE (1) SE8303886L (xx)
ZA (1) ZA834978B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
PL193976B1 (pl) 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203691A (en) * 1968-03-06 1970-09-03 Science Union & Cie New disubstituted n-amino indoline derivatives and process for preparing them
GB1308191A (en) * 1970-04-06 1973-02-21 Science Union & Cie Thiochroman derivatives and a process for preparing them
IL39625A0 (en) * 1971-06-15 1972-11-28 Ciba Geigy Ag New pharmaceutical preparations for the treatment of hypertonia,containing a diuretic and a beta-receptor blocking agent

Also Published As

Publication number Publication date
IT1173729B (it) 1987-06-24
AU557601B2 (en) 1986-12-24
AU1670283A (en) 1984-01-12
ZA834978B (en) 1984-03-28
IE831597L (en) 1984-01-09
DE3324785C2 (de) 1986-10-09
GB2123293A (en) 1984-02-01
GB2123293B (en) 1985-10-09
IT8348641A0 (it) 1983-07-07
FR2529785B1 (xx) 1984-12-07
NL8302435A (nl) 1984-02-01
SE8303886D0 (sv) 1983-07-07
CH655007A5 (fr) 1986-03-27
SE8303886L (sv) 1984-01-10
FR2529785A1 (fr) 1984-01-13
IE55364B1 (en) 1990-08-29
DE3324785A1 (de) 1984-01-12
LU84902A1 (fr) 1984-03-22
GB8318512D0 (en) 1983-08-10
OA07489A (fr) 1985-03-31
BE897251A (fr) 1984-01-09
NZ204849A (en) 1986-04-11
JPS5927813A (ja) 1984-02-14
JPH0250084B2 (xx) 1990-11-01

Similar Documents

Publication Publication Date Title
US4066756A (en) Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin
EP1108424B2 (fr) Comprimé matriciel permettant la libération prolongée de trimétazidine après administration par voie orale
FR2550444A1 (fr) Preparation solide capable de liberer rapidement la dihydropyridine a, et son procede d'obtention
CZ147494A3 (en) Pharmaceutical preparation and process for preparing thereof
US20100204190A1 (en) New combinations
CA1197191A (fr) Composition pharmaceutique antihypertensive synergetique
GB2209281A (en) Pharmaceutical compositions containing alpha-2 adrenoceptor antagonists
FR2489146A1 (fr) Composition pharmaceutique a liberation prolongee a base d'une substance medicamenteuse solide
FR2548900A1 (fr) Compositions pharmaceutiques synergiques
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
EP1115399B1 (fr) Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour la fabrication d'un medicament pour traiter les glomerulonephrites chroniques
KR102267965B1 (ko) 베타 차단제, 전환 효소 억제제 및 항고혈압제 또는 nsaid를 포함하는 약학적 조성물
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
US20160346249A1 (en) Use of amitifadine, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in methods and compositions with enhanced efficacy and reduced metabolic side effects and toxicity for treatment of depression and other central nervous system disorders and conditions affected by monoamine neurotransmitters
EP2026796B1 (fr) Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire
CH677731A5 (en) Use of isoquinoline derivs.
FR3027803A1 (fr) Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion
Rahmani Vascular smooth muscle, endothelial regulation and effects of aspirin in hypertension
FR2464071A1 (fr) Preparation pharmaceutique a base de dihydro-ergotamine et d'heptaminol
JPS6232721B2 (xx)
AU4743399A (en) Treating conditions with (+)-liarozole
WO1982004392A1 (en) Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
BE825194A (fr) Hydrazide de n-benzene-sulfonyl-beta-alanine comme agent immunosupressif sur et actif
AU4743699A (en) Treating conditions using optically pure (-)-liazrozle

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry